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Abstract
Blood coagulation occurs through a cascade of enzymes and cofactors that produces a fibrin clot, while otherwise
maintaining hemostasis. The 11 human coagulation factors (FG, FII–FXIII) have been identified across all vertebrates,
suggesting that they emerged with the first vertebrates around 500 Ma. Human FVIII, FIX, and FXI are associated with
thousands of disease-causing mutations. Here, we evaluated the strength of selective pressures on the 14 genes coding for
the 11 factors during vertebrate evolution, and compared these with human mutations in FVIII, FIX, and FXI. Positive
selection was identified for fibrinogen (FG), FIII, FVIII, FIX, and FX in the mammalian Primates and Laurasiatheria and the
Sauropsida (reptiles and birds). This showed that the coagulation system in vertebrates was under strong selective
pressures, perhaps to adapt against blood-invading pathogens. The comparison of these results with disease-causing
mutations reported in FVIII, FIX, and FXI showed that the number of disease-causing mutations, and the probability of
positive selection were inversely related to each other. It was concluded that when a site was under positive selection, it
was less likely to be associated with disease-causing mutations. In contrast, sites under negative selection were more likely
to be associated with disease-causing mutations and be destabilizing. A residue-by-residue comparison of the FVIII, FIX,
and FXI sequence alignments confirmed this. This improved understanding of evolutionary changes in FVIII, FIX, and FXI
provided greater insight into disease-causing mutations, and better assessments of the codon sites that may be mutated
in applications of gene therapy.
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Introduction
Blood coagulation involves a complex yet regulated cascade
of over two dozen proteins in blood (Doolittle 2009). Most of
these proteins are serine protease enzymes and circulate in
blood as inactive zymogens waiting for an activation trigger
such as proteolytic cleavage. For coagulation, this trigger is
usually some form of vascular injury, followed by activation. In
the classical waterfall model, each activated protein goes on
to activate the next protein in a rapidly expanding cascade of
reactions which quickly results in the local formation of a
fibrin clot to seal the injury (Spronk et al. 2003). The 11
human coagulation factor proteins in blood are usually indi-
cated by F and a Roman numeral and followed by a lowercase
“a” to indicate their active form, namely FG, FII, FIII, FV, FVII,
FVIII, FIX, FX, FXI, FXII, and FXIII (Kawthalkar 2013). FG is
comprised of the , , and  genes of fibrinogen (FG)
(FGA, FGB, and FGG) while FXIII is produced from two
genes F13A and F13B. Thus these 11 coagulation factor pro-
teins are produced by 14 genes (table 1). The two central
processes during coagulation are the conversion of prothrom-
bin (FII) to thrombin (FIIa) that cleaves FG to form fibrin,
followed by the polymerization of fibrin to form the fibrin
clot. The classic waterfall cascade model involved three path-
ways (intrinsic, extrinsic, and common) where the intrinsic
pathway is first triggered upon injury through FXII and the
extrinsic pathway is triggered by the exposure of intracellular
tissue factor (FIII) to FVII in serum after which tissue factor
binds to and activates FVII. Recent advances in molecular
biology have revealed that the waterfall model does not prop-
erly account for the roles of tissue factor and FVII (Broze
1995). In the revised waterfall model (fig. 1), thrombin gener-
ation occurs in two phases. The initiation phase caused by
tissue damage results in relatively low thrombin activation,
followed by the amplification (propagation) phase where the
bulk of activated thrombin is formed (Butenas et al. 2000).
Although the classical model remains useful as a laboratory
model of coagulation, the revised model is more effective and
logical in laboratory-based screening for coagulation factor
abnormalities in bleeding disorders.
Many of the coagulation proteins are related to each other
via gene duplications that occurred early in vertebrate evolu-
tion between the appearance of protochordates and the jaw-
less fish (Doolittle et al. 2008; Doolittle 2009). Two rounds of
whole-genome duplications occurred at the beginning of ver-
tebrates, and a third one occurred at the beginning of teleost
fishes (Meyer and Van de Peer 2005). In all vertebrates during
evolution, blood coagulation retained a central mechanism in
which the generation of thrombin resulted in fibrin clot for-
mation. During evolution, several coagulation factors that
depend on others for their activity have been altered in a
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complex fashion, starting from the first vertebrates. Sequence
analyses have revealed the order in which the factors evolved
(Doolittle 2009). There is considerable interest in the evolu-
tionary development of the complexity of coagulation in
mammals. This is driven by the importance of understanding
pathogenic disease-causing mutations in humans, as well as
understanding how a well-regulated cascade of enzymatic
reactions is developed, and obtaining new insights into its
molecular mechanism. Analyses of the known mutations in
patients and comparison with the mutations tolerated
during evolution will clarify which codons are stable and
which are not.
The coagulation system overlaps with the innate immune
system and the complement proteins through their common
properties involving vascular permeability. Deficiencies in the
coagulation proteins, mostly due to genetic variations, are
associated with a spectrum of genetic disorders that range
from life-threatening ones such as severe Hemophilia A (as-
sociated with FVIII) to milder variants (table 1). Hemophilia A
and B are more common than the others, while some are rare,
and these diseases prevail because their underlying genetic
mutations are passed on from generation to generation.
Replacement therapies using recombinant coagulation pro-
teins are expensive. More recently, FIX gene therapy trials for
Hemophilia B patients have been successful (Nathwani et al.
2011), and this method is yet to be applied to FVIII and other
coagulation proteins. A major problem faced in FIX gene
therapy is the low level of protein expression, in part due to
a different codon usage in the organism that produces the
protein (Thomas et al. 2003). An evolution-driven study of
the codons in the FIX gene may help identify which codons
could be altered to increase protein expressions in the pro-
ducing organism and in the meantime be tolerated in the
host.
Table 1. The 14 Coagulation Genes and Their Protein Products.
Gene ENSEMBL ID Protein Product Other Name Function Genetic Disorder Amino Acid
Length
No. of
Domains
Domain Organization
FGA ENSG00000171560 Coagulation
Factor I
Fibrinogen alpha
chain
Forms fibrin clot;
cofactor in
platelet
aggregation
Congenital afibro-
genmia, famil-
ial renal
amyloidosis
866 1 Fibrinogen C-terminal
domain
FGB ENSG00000171564 Fibrinogen beta
chain
491 1 Fibrinogen C-terminal
domain
FGG ENSG00000171557 Fibrinogen gamma
chain
453 1 FG C-terminal domain
F2 ENSG00000180210 Coagulation
factor II
Prothrombin Activates FG to
fibrin
Thrombophilia 622 4 Gla–Kringle 1–Kringle
2–SP
F3 ENSG00000117525 Coagulation
factor III
Tissue factor Activates FVIIa — 295 3 Transmembrane–trans-
membrane helix–
transmembrane
F5 ENSG00000198734 Coagulation
factor V
Proaccelerin Combines with
FX to activate
prothrombin
Activated protein
C resistance
2224 6 F5/8 type A1–F5/8 type
A2–B–F5/8 type A3–
F5/8 type C1–F5/8
type C2
F7 ENSG00000057593 Coagulation
factor FVII
Proconvertin Activates FIX, FX Congenital pro-
convertin/
factor VII
deficiency
466 4 Gla–EGF1–EGF2–SP
F8 ENSG00000185010 Coagulation
Factor FVIII
Antihemophilic
factor A (AHF-
A)
Combines with
FIX and FIV to
activate FX
Hemophilia A 2351 6 F5/8 type A1–F5/8 type
A2–B–F5/8 type A3–
F5/8 type C1–F5/8
type C2
F9 ENSG00000101981 Coagulation
factor FIX
Christmas factor Combines with
FVIII and FIV
to activate FX
Hemophilia B 461 4 Gla–EGF1–EGF2–SP
F10 ENSG00000126218 Coagulation
factor FX
Stuart-prower
factor
Converts pro-
thrombin to
thrombin
Congenital factor
X deficiency
488 4 Gla–EGF1–EGF2–SP
F11 ENSG00000088926 Coagulation
factor FXI
Plasma thrombo-
plastin
antecedent
Combines with
FIV to activate
FIX
Factor XI
deficiency
625 4 Apple 1–apple 2–apple
3–SP
F12 ENSG00000131187 Coagulation
factor FXII
Hageman factor Activates FXI; ac-
tivates plasmin
Hereditary
angioedema
type III
615 6 Fibronectin type-II–
EGF1–fibronectin
type-I - EGF2–krin-
gle–SP
F13AENSG00000124491 Coagulation
factor FXIII
Fibrin-stabilizing
factor A chain
Stabilizes fibrin Congenital factor
XIIIa deficiency
732 — —
F13B ENSG00000143278 Fibrin-stabilizing
factor B chain
Stabilizes FXIIIA;
regulates
thrombin
Congenital factor
XIIIb deficiency
661 10 Short complement regu-
lator domains 1–10
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In order to interpret the effect of evolutionary and muta-
tional changes in coagulation, we have examined FVIII, FIX,
and FXI. For FVIII, 5,474 disease-causing mutations have
been recently compiled (Rallapalli PM, Kemball-Cook G,
Tuddenham EG, Gomez K, Perkins SJ, unpublished data;
http://www.factorviii-db.org/, last accessed January 2014),
3,713 mutations were recently published for FIX (Rallapalli
et al. 2013; http://www.factorix.org/, last accessed January
2014) and 487 mutations are known for FXI (Saunders et al.
2009; http://www.factorxi.org/, last accessed January 2014). We
identified 47 full genomes in the Ensembl database that
showed good sequence coverage. This enabled the assessment
of positive or negative selection pressures (Yang 2006) in the
evolution of coagulation protein sequences. The identification
of positive selection in at least nine of the 11 coagulation
proteins during different periods of evolution showed that
an effective coagulation pathway was under considerable
adaptive constraints, even in primates. The mutational analy-
ses for FVIII, FIX, and FXI showed that disease-causing muta-
tions primarily affected highly conserved residues under
negative selection, and damaged protein stabilities. This joint
evolutionary-mutational study provides novel clarifications of
the observed data on pathogenic mutations and may facilitate
new gene therapy approaches for their treatments.
Results
Selection of 47 Genomes
A data set of 14 coagulation factor genes (table 1) that code
for 11 proteins across different groups of vertebrate genomes
(fig. 2) was identified from the Ensembl database. The
Ensembl database currently holds 78 genomes. Of these,
only 47 vertebrate genomes were chosen based on their se-
quence coverage and assembly quality (fig. 2). Ensembl gene
sets are built from assemblies of DNA sequences and protein
information, hence it was important to select only good-
quality assemblies for the gene trees and sequence data sets
used in this study. The 47 vertebrate genomes were classified
into five major clades based on the Ensembl classification,
namely Primates, Glires, Laurasiatheria, Sauropsida, and
Fishes. The mammalian clade of 30 genomes consisted of
three clades used in our study (Primates, Glires, and
Laurasiatheria) and other clades (Atlantogenata and
Australian mammals) (fig. 2). The codon substitution site-
models M1a, M2a, M7, M8, and M8a from CodeML
(Materials and Methods) were used to calculate the selection
pressures on the five major clades, each with at least seven
sequences, to ensure that the CodeML calculations were rea-
sonably powerful (Anisimova et al. 2002). By following this
FIG. 1. Schema of the blood coagulation pathway leading to fibrin. The relationships between the 11 coagulation factors that are coded by 14 genes are
shown in the modern revised coagulation pathway (blue, enzymes; red, cofactors). Tissue factor (TF; also known as FIII) initiates coagulation when it
binds and activates FVII. The activated TF-FVIIa complex then activates FX which then generates activated thrombin (FIIa). FVIII, FIX, and FXI enable the
amplification of the coagulation pathway to maximize FIIa production, and possess the largest number of pathogenic human mutations. Activated
thrombin cleaves FG (FI; green) to form fibrin polymers (blood clots) that are cross-linked by FXIIIa.
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criterion, the Atlantogenata clade with only five sequences
was eliminated from the selection pressure calculations. The
multiple sequence alignments from Ensembl were realigned
using a strict quality control procedure (supplementary fig.
S1, Supplementary Material online), which was performed in
order to minimize the number of false positive results below.
Presence and Absence of Coagulation Factors
The 47 genomes were searched for the 14 genes coding for
the 11 coagulation factors. In cases where the Ensembl gene
tree for a given coagulation factor did not show the presence
of a particular genome, we searched for putative genes across
that genomic sequence to establish whether the organism
had lost them. The purpose of the coagulation cascade is to
convert FG into the fibrin clot, and unsurprisingly FG (the
FGA, FGB, and FGG genes) was found in all 47 genomes. The
other central genes thrombin (F2), tissue factor (F3), the
coagulation cascade cofactors (F5 and F8), F7, F9, and F10
were present across all 47 genomes from fishes to humans.
F11 is present in all Sarcopterygii (tetrapods and coelacanth),
but seems to have been lost or highly diverged in teleost
fishes, because it is only recorded in the spotted gar
Lepisosteus oculatus, which belongs to Holostei, a sister
clade of teleost fishes. F12 appeared in the ancestor of tetra-
pods, and is absent in fishes, but present in amphibians
(Xenopus tropicalis), reptiles (Anolis carolinensis), and mam-
mals. For F13, the alpha chain (F13A) was observed to appear
from the time of vertebrates, because this gene has been
found in the sea lamprey, fishes, and tetrapods. The beta
chain (F13B) appears to be present at the origin of vertebrates,
because F13B sequences have been recorded in cave fish
(Astyanax mexicanus) and medaka (Oryzias latipes).
Occasionally a gene was not reported; this was most likely
to arise from incomplete or unidentified sequences.
FIG. 2. Phylogenetic tree of 47 vertebrate genomes. The tree shows the 47 genomes studied here alongside their clade and taxonomic groups. The 47
vertebrate genomes showed good sequence quality and coverage in the Ensembl database and were grouped into five major clades (Primates, Glires,
Laurasiatheria, Sauropsida, and Fishes) and three minor clades. The Mammals comprised of the Primates, Glires, and Laurasiatheria clades together with
Atlantogenata (African origin mammals and Xenartha) and four Australian species, totaling 30 out of 47 genomes.
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Selective Pressures Using Codon Substitution
Site-Models
Codon substitution site-models from the CodeML package
were used to analyze the protein-coding sequences in the 14
genes following the quality control of their alignments. The
models assume that selective pressure does not act equally on
the entire protein sequence but varies between amino acid
sites in a gene family. We calculated the log likelihood values
(lnL) of five different selection models (M1a, M2a, M7, M8,
and M8a) in order to perform the likelihood ratio test (LRT).
The five models differed from each other in the number of
parameters (np) considered and their variable! values. The!
value is the ratio of nonsynonymous and synonymous sub-
stitution rates (dN/dS) (Materials and Methods). The compar-
ison between a null model that does not consider !4 1
(M1a, M7, or M8a) and an alternate model that considers
!4 1 (M2a or M8) is a measure of positive selection.
If the null (neutral) model is rejected in favor of the
alternate (selection) model, positive selection is inferred
(Yang 2006).
To evaluate the five models, the LRT value was calculated
as follows:
LRT ¼ 2ðlnLalternate lnLnullÞ
where lnL is the maximum-likelihood estimate of the proba-
bilities of selection. The LRT is asymptotically distributed as a
2k function where k (also known as the degrees of freedom) is
the difference between the np in the null and alternate
models. The np values were calculated along with the lnL
values in CodeML.
k ¼ npalternate  npnull
The LRT values for which the 2k distribution shows a P
value< 0.05 indicated that some sites were significantly
under positive selection. For this study, the comparison of
the M8a null model with the M8 alternate model (referred to
as M8a-M8) was considered optimal to infer positive selection
(table 2). The LRT M1a-M2a is too conservative, whereas M7–
M8 was considered to be more problem prone and less ac-
curate compared with M8a-M8 (Wong et al. 2004; Studer and
Robinson-Rechavi 2009b). Because the P values result from
multiple tests performed using different genes at different
clade levels, it was necessary to control for the expected pro-
portion of false positives. False positives were accounted for
by calculating the q value correction over the P value for the
different genes in each clade, this approach being both pow-
erful and specific (Studer et al. 2008).
The overall picture is that a total of nine coagulation factor
proteins (out of the 11 of the cascade) underwent positive
selection at one or more stages in evolution (fig. 3). The
highest number of genes under positive selection within an
individual clade is five (for vertebrates and mammals). For
Vertebrates, using the LRT M8a-M8, positive selection was
found in as many as five of the 14 coagulation genes (table
2). In figure 3a, these included F2, F5, F7, F10, and F13A for all
47 vertebrates. In figure 3b, these included FGA, F3, F5, F8, and
F9 for the 30 mammals. In figure 3c–e, these included FGB, F5,
and F8 (Primates); FGA and F13B (Laurasiatheria), and F3
(Sauropsida). FG (FG= FGA+ FGB+ FGG) and F5 were ob-
served to undergo the most extensive positive selection com-
pared with any other coagulation genes. The selective
pressure on all the genes in different clades was identified
from the LRT values (table 2), except for those of F11 in
Laurasiatheria, Sauropsida, and Fishes, F12 in Sauropsida and
Fishes, and F13B in Fishes because these genes were
absent (supplementary table S1, Supplementary Material
online).
Estimation of Selective Pressures Using Branch-Site
Model of Codon Substitution
The above site models estimated selective pressures that vary
among amino acid positions across multiple species. But se-
lective pressures can also vary among species (Studer and
Robinson-Rechavi 2009a), and codon substitution branch-
site models have been developed to detect such episodic
positive selection (Zhang et al. 2005). Here, we have used
the results of the branch-site model from two different
sources, one from the Selectome database, and the other
from our own calculations. Both approaches employed
CodeML on the two data sets of this study (Materials and
Methods) in order to check for consistency with the positive
selection identified in the site-model calculations (fig. 3).
Similar to the site model, the false positives in our branch-
site model calculations were accounted for by calculating the
q value correction over the P value for the different genes in
each clade. For both branch-site calculations, we followed the
taxonomic grouping in the Selectome database (supplemen-
tary table S2b, Supplementary Material online). The highest
order of classification is the Sarcopterygii (coelacanths, lung-
fish, and tetrapods), followed by its largest subgroup
Tetrapoda (mammals, sauropsids, and frogs). Other major
taxonomic subtrees were those of amninots, sauropsids,
mammals, theria, and eutheria. The Actinopterygii (fishes)
and Sauropsida (birds) are common to both the calculations.
The Eutheria and mammalian subtree calculations from the
Selectome database were considered to be equivalent to the
mammalian clade of our analyses (fig. 2). Positive selection
across the vertebrates was observed for all genes except FGG,
F3, F7, and F11 in our branch-site model calculations (supple-
mentary table S2b, Supplementary Material online). We ob-
tained similar results with our site-model calculations
(supplementary table S2a, Supplementary Material online),
except for the exclusion of F3 and F7 (fig. 3a). Our branch-
site calculations identified positive selection in mammalian
FGB, F2, F8, and F9, whereas the site model identified positive
selection in mammalian FGA, F3, F5, F8, and F9. Overall FG
(FGA, FGB), F8 and F9 were consistently identified to be pos-
itively selected in mammals, whereas F5 shows positive selec-
tion up to amniotes, after which the mammals and the
sauropsids clade split. In conclusion, the two branch-site
and the site models all suggested signatures of positive selec-
tions across F8 and F9, whereas no such selection was
observed across and between F11.
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Identification of Codon Sites under Positive Selection
For up to 11 genes out of 14 identified to be under positive
selection (table 3), further analyses were performed to identify
which codon sites were under such selection. This was done
using the Bayes Empirical Bayes (BEB) method from the M8
site-model (Yang et al. 2005). The number of codons poten-
tially under positive selection (BEB 450%) in the positively
selected genes ranged between 3 and 64. But the number of
codons accurately predicted under positive selection (BEB
495%) is actually much lower (between 0 and 4). The FGA
gene in Laurasiatheria showed the highest percentage of pos-
itively selected codons (13.29%, as estimated by CodeML, and
64 codons detect, with two at BEB495%), followed by the F5
gene in Primates (13.21%, with 54 codons, all BEB<95 %). The
smallest percentage of positively selected codons was ob-
served in the F10 gene of Vertebrates (0.01% with three
codons, all with BEB <95%). No positive selection was ob-
served in any of the codon sites for the FGG, F11, and F12
genes in the taxa groups of this study.
Table 2. LRT Statistics for the Site Model Comparisons of Model 8
with Model 8a for the 14 Coagulation Factors among the Five Clades.
Gene Clade No. of
Sequences
No. of
Codons
(M8a-M8)
LRT P value q value
FGA Vertebrates 44 236 1.39 0.24 0.35
Mammals 29 288 7.75 0.01** 0.04*
Primates 7 865 3.35 0.07 0.16
Glires 7 670 2.89 0.09 0.19
Laurasiatheria 9 267 7.28 0.01** 0.04*
Sauropsida 6 464 0.33 0.57 0.62
Fishes 7 592 0.16 1.00 0.72
FGB Vertebrates 40 429 1.45 0.23 0.35
Mammals 26 456 2.78 1.00 0.72
Primates 6 488 7.44 0.01** 0.04*
Glires 6 471 0.69 0.41 0.51
Laurasiatheria 8 479 1.44 0.23 0.35
Sauropsida 5 473 0.02 1.00 0.72
Fishes 7 476 0.99 1.00 0.72
FGG Vertebrates 44 386 1.74 1.00 0.72
Mammals 29 427 3.19 0.07 0.17
Primates 7 433 3.98 0.05* 0.13
Glires 7 433 3.44 0.06 0.16
Laurasiatheria 8 432 0.09 0.76 0.72
Sauropsida 5 427 0.03 0.86 0.72
Fishes 8 395 5.42 1.00 0.72
F2 Vertebrates 38 475 16.91 0.00** 0.00**
Mammals 23 571 4.64 0.03* 0.11
Primates 7 621 4.25 0.04* 0.12
Glires 5 611 0.07 1.00 0.72
Laurasiatheria 7 620 1.58 0.21 0.34
Sauropsida 5 593 3.68 0.05 0.14
Fishes 8 562 0.05 1.00 0.72
F3 Vertebrates 47 166 2.09 0.15 0.27
Mammals 26 240 13.37 0.00** 0.00**
Primates 7 295 0.01 0.90 0.72
Glires 6 287 3.07 0.08 0.18
Laurasiatheria 7 292 0.97 0.32 0.44
Sauropsida 5 254 8.65 0.00** 0.02*
Fishes 14 192 0.82 0.36 0.47
F5 Vertebrates 37 1,182 14.95 0.00** 0.00**
Mammals 22 1,741 31.92 0.00** 0.00**
Primates 6 2,116 5.36 0.02* 0.08*
Glires 6 1,847 0.48 0.49 0.56
Laurasiatheria 6 2,043 4.83 0.03* 0.10
Sauropsida 5 1,550 1.45 0.23 0.35
Fishes 8 1,534 2.12 0.15 0.27
F7 Vertebrates 34 330 5.93 0.01** 0.07*
Mammals 29 344 3.06 0.08 0.18
Primates 7 443 0.16 0.69 0.72
Glires 7 417 0.3 1.00 0.72
Laurasiatheria 7 443 0.57 0.45 0.54
Sauropsida 3 425 0.55 0.46 0.54
Fishes NA
F8 Vertebrates 38 1,028 4.85 0.03* 0.10
Mammals 24 1,985 11.19 0.00** 0.01**
Primates 7 2,351 6.83 0.01** 0.04*
Glires 5 2,257 3.95 0.05* 0.13
Laurasiatheria 7 2,344 0.25 0.62 0.67
Sauropsida 5 1,480 0.03 0.86 0.72
Fishes 7 1,413 0.9 0.34 0.45
F9 Vertebrates 44 329 0.63 0.43 0.52
Mammals 24 443 18.57 0.00** 0.00**
Primates 7 461 1.28 0.26 0.36
Glires 5 468 1.85 0.17 0.30
(continued)
Table 2. Continued
Gene Clade No. of
Sequences
No. of
Codons
(M8a-M8)
LRT P value q value
Laurasiatheria 7 459 4.34 0.04* 0.12
Sauropsida 5 435 0.03 1.00 0.72
Fishes 13 368 0.36 1.00 0.72
F10 Vertebrates 41 353 14.55 0.00** 0.00**
Mammals 26 424 0.23 0.63 0.67
Primates 7 485 0.01 0.91 0.72
Glires 6 464 2.06 0.15 0.27
Laurasiatheria 7 463 2.3 0.13 0.25
Sauropsida 5 385 0.03 0.87 0.72
Fishes 8 391 0.71 0.40 0.51
F11 Vertebrates 23 614 0.34 0.56 0.62
Mammals 23 614 0.34 0.56 0.62
Primates 7 625 0.05 0.82 0.72
Glires 5 619 0.07 0.79 0.72
Laurasiatheria 6 625 0.02 0.89 0.72
Sauropsida NA
Fishes NA
F12 Vertebrates 27 512 3.98 1.00 0.72
Mammals 25 533 0.18 1.00 0.72
Primates 7 615 0.02 1.00 0.72
Glires 6 557 0.07 1.00 0.72
Laurasiatheria 8 513 4.6 0.03* 0.11
Sauropsida NA
Fishes NA
F13A Vertebrates 47 631 9.07 0.00** 0.02*
Mammals 26 684 2.58 0.11 0.22
Primates 7 732 1.62 0.20 0.34
Glires 6 730 1.47 1.00 0.72
Laurasiatheria 9 730 0.27 1.00 0.72
Sauropsida 5 732 0.01 0.92 0.72
Fishes 14 643 2.59 0.11 0.22
F13B Vertebrates 31 609 1.3 0.25 0.36
Mammals 25 640 1.57 0.21 0.34
Primates 7 660 1.22 0.27 0.37
Glires 5 634 0.21 1.00 0.72
Laurasiatheria 7 656 7.08 0.01** 0.04*
Sauropsida 5 573 0.93 1.00 0.72
Fishes NA
NOTE.—Positive selection is denoted in bold in column 2.
*P< 0.05; **P< 0.01
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Disease-Causing Missense Mutations and Relationship
to Evolutionary Pressures
The relationship between selective pressure and the proba-
bility of disease-causing mutations at a codon site is of great
interest. Disease-causing missense mutations have been re-
ported in all 14 coagulation genes, in particular for
Hemophilia A (F8), Hemophilia B (F9), factor XI deficiency
(F11), and thrombophilia (F2) (table 1). Extensive compila-
tions of 487–5,474 disease-causing mutations are available for
three of these coagulation factors FVIII, FIX, and FXI,
(Saunders et al. 2009; Rallapalli et al. 2013; Rallapalli et al.
2014 [unpublished data]). There is a sufficient number of
pathogenic mutation and evolutionary selection data from
the FVIII, FIX, and FXI proteins to enable us to compare in
statistical detail the correlation between selective pressure
and disease-causing mutations.
For the comparison of the FVIII, FIX, and FXI protein
changes, selective pressures were identified using the BEB in-
ference method from model M2a (fig. 4). While powerful, a
disadvantage of Model M8 is that it classifies sites into 11
categories (ten in negative/neutral and one positive selec-
tion). These 11 categories can vary between different gene
families, making the comparison difficult. Thus, model M2a is
advantageous in that this has only three distinct categories,
namely negative selection (dN/dS< 1), neutral evolution (dN/
dS = 1) and positive selection (dN/dS4 1). Under the M1a-
M2a test in the primates clade, two genes (F8 and F9) showed
positive selection, whereas F11 did not show positive selec-
tion, which differs from that shown in figure 3c which is based
on the M8 model. The posterior probabilities of neutral, neg-
ative, and positive selection for the FVIII, FIX, and FXI proteins
showed that positive selection occurred in specific codons,
the most being for F8 and the fewest for F11. For completion,
the same analysis for the other 11 genes is shown in supple-
mentary table S2, Supplementary Material online. These show
similar outcomes to those for FVIII, FIX, and FXI.
For each amino acid position in FVIII, FIX, and FXI, we
compared its selective pressure (positive, neutral, or negative)
FIG. 3. Positively selected genes of the coagulation cascade in vertebrates, mammals, and three major clades. The layout of this figure is a simplified
representation of figure 1. Genes showing significant positive selection in the LRT calculations are highlighted in red. (a) Positive selection was observed
in five genes when all 47 genome sequences (vertebrates) were analyzed as a single group. (b) In the Mammals group (fig. 2), where positive selection is
seen for five genes, only the (c) Primates and (d) Laurasiatheria clades are shown with positive selection for two or three genes only, because no positive
selection was seen in the Glires clade whereas insufficient sequences were available in the Atlantogenata clade for conclusions to be drawn. (e) Positive
selection was seen in the Sauropsida, clade but no positive selection was observed in Fishes (fig. 2).
3046
Rallapalli et al. . doi:10.1093/molbev/msu248 MBE
 at U
CL Library Services on N
ovem
ber 21, 2014
http://m
be.oxfordjournals.org/
D
ow
nloaded from
 
with the reported number of disease-causing mutations. The
outcome was presented using regression plots (fig. 5).
The regression plots and their correlation coefficients revealed
the relationship between the selection probability values at
amino acid sites with the disease-causing mutations at those
sites. The average probability of a site to be under positive
selection and its number of disease-causing mutations
showed a negative relationship with correlation coefficients
of 0.85, 0.67, and 0.95 in FVIII, FIX, and FXI, respectively
(fig. 5, top row). The correlation coefficients for neutral selec-
tion followed that of positive selection with values of 0.87,
0.64, and 0.96 for FVIII, FIX, and FXI, respectively (fig. 5,
middle row). In distinction to these, a positive relationship
was seen between the average probability of negative selec-
tion and the disease-causing mutations, with correlation co-
efficients of +0.86, +0.66, and +0.95 for FVIII, FIX, and FXI,
respectively (fig. 5, bottom row). To summarize, the fewer the
number of disease mutations at a given site, the higher is the
probability for positive selection or neutral evolution (fig. 5,
top row and middle row). The greater the number of disease-
causing mutations at a given site, the higher the probability
for negative selection (fig. 5, bottom row). The comparison
between the positively selected proteins FVIII and FIX with
the nonpositively selected protein FXI is noteworthy.
Irrespective of the selective pressure, all three proteins ex-
hibited similar regression lines in each of the three rows.
These comparisons show that there is a general inverse pro-
portionality relationship between the probability of positive
selection (or neutral evolution) and the number of disease-
causing mutations at each site. This confirms previous obser-
vations that disease-causing mutations tend to occur at crit-
ical sites in the protein and that these highly conserved sites
are less tolerant to new mutations (negative selection).
Stability Effect of Mutations
In order to explain the consequences of disease-causing mu-
tations on the protein structure, FoldX software was used to
Table 3. Positively Selected Sites in the M8a-M8 Comparison.
Gene Clade No. of
Codons
Analyzed
No. of Codons
under positive
selection
Percentage
Estimated by
CodeML (%)
Sites under Positive Selection (BEB4 50%)
FGA Mammals 288 13 7.17 7,18,32,35,39,51,101,108,178*,212,219,246,273
FGA Laurasiatheria 267 64 13.29 4,6*,7,12,19,29,30,33,36,40,52,93,94,96,97,100,102,103,108,
109,116,117,118,123,136,138,141,143,155,171,180,182,
195,208,210,213,214,216,218,219,220,222,223,225,227,
229,231,232,233,234,236,239,242,244,245,250,253,254*,
256,259, 260,261,264,265
FGB Primates 488 17 8.22 39*,41,55,80,81,82,130,134,135*,137,173,290,
367,388,413,415,448
F2 Vertebrates 475 5 0.99 52,57,151,162,381
F3 Mammals 240 11 6.63 55,72,76,91,115,177,179,185*,195,230,240
F3 Sauropsida 254 13 10.60 3,40,41,44,74,79,80,81,110,123,170,208,249*
F5 Vertebrates 1,182 10 0.87 103,275,574**,578*,593*,602,777,926,995,1010
F5 Mammals 1,741 54 2.72 2,3,7,24,36,60,134**,389*,392,656,663,667,669, 676**,680*,
718,720,731,745,749,765,768,782,809,819,822,824,875,
880,894,895,907,911,916,928,930,945,967,976,989,1016,
1040,1076,1080,1089,1136,1139,1324,1471,1479,1515,
1522,1548,1564
F5 Primates 2,116 54 13.21 7,40,52,129,180,211,336,341,408,409,434, 592,660,703,707,
720,754,784,877,879,888,892,907,941,959,978,1033,1039,
1059,1131,1168,1205,1209,1218,1220,1222,1230,1231,
1232,1236,1244,1254,1262,1265,1279,1285,1498,1504,
1519,1526,1667,1682,1849,1918
F7 Vertebrates 330 12 5.22 5,6*,52,66,88*,162,167,178,179,209,258,262
F8 Mammals 1,985 27 3.98 7,245,281,339,342,521,667,718,765,784,
785,792,807,817,889,912,1130,1193,1197,
1220,1229,1288,1308,1333,1686,1967,1984
F8 Primates 2,351 33 0.63 422,755,791,814,850,860,886,927,964,966,
979,988,996,1019,1071,1180,1282,1312,
1361,1414,1421,1436,1438,1459,1527,1582,
1613,1622,1650,1689,1730,2340,2349
F9 Mammals 443 15 4.40 4,5,100*,114**,140*,150,177,181,
199**,202,206,209,270,309,348
F10 Vertebrates 353 3 0.01 1,44,70
F13A Vertebrates 631 6 1.26 398,489*,497,502,550,613
F13B Laurasiatheria 656 18 1.52 5,56,73,78,107,341,349,350,374,443,
459,461,497,522,525,539,540,624
*P4 95%; **P4 99%.
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estimate the stability effect (G) of residue changes on the
three-dimensional structures of human FVIII (chains A and B),
FIX, and FXI (fig. 6). FoldX was designed to predict the stability
effect of a mutation. This is an empirical method that relies on
the estimation of physical parameters from more than 1,000
mutations in protein structures, and has been evaluated with
21 proteins (Schymkowitz et al. 2005; Tokuriki et al. 2007).
First, each amino acid at each position was replaced with each
of the other 19 amino acids in order to provide a baseline for
comparison. As expected, the prediction of all virtual muta-
tions shows a distribution skewed toward destabilization (me-
dians G range between 0.51 and 1.23 kcal/mol). Next, the
effect of changing the human amino acids with those seen in
evolution for the other 46 sequences of this study was calcu-
lated in order to examine the effect of evolutionary change on
protein stabilities. This produced a narrow distribution pre-
dominantly centered on a difference of stability G of
0 kcal/mol, and showing a slight skew toward deleterious mu-
tations (medians G range between 0.14 and 0.30 kcal/
mol). This outcome is as expected because evolutionary
changes in the amino acids are selected in order to preserve
the stability of the protein structures. Finally, the effect of
changing the human amino acids to those observed in
unique pathogenic missense mutations was calculated. This
analysis produced a clearly skewed distribution (medians
G range between 1.01 and 2.95 kcal/mol) of G
values that ranged as high as 10 kcal/mol (and even higher,
but these higher values were clipped for easier visualization);
this agrees with the fact that these mutations affect the pro-
tein structure. The first distribution for the virtual mutations
is intermediate between the latter two distributions as
expected.
The same outcome of stability effects was also observed at
the individual amino acid level (fig. 7). When the effect of 19
amino acid replacements were computed at each position for
FVIII, FIX, and FXI, and the majority of replacements showed a
destabilizing effect (41.0 kcal/mol, in red). A small propor-
tion of replacements stabilized the structure (<1.0 kcal/
mol, in blue), indicating the ability of the protein to compen-
sate deleterious mutations by further mutation. Although this
appears to occur more strongly for the FVIII chains A and B
(fig. 7a and b), the proportion of allowed replacements is in
fact similar for all four proteins when their different sizes are
considered. When the effect of replacements by disease-caus-
ing missense mutations was calculated, and the G values
showed that these almost invariably destabilized the three
protein structures.
Discussion
In this study, we have assembled sequence data for 14 coag-
ulation genes across 47 genomes in order to analyze the evo-
lutionary changes in amino acids that take place between five
FIG. 4. Probability of evolutionary selection across the Primates clade for the three proteins FVIII, FIX, and FXI. The probabilities of negative, neutral, and
positive selection were plotted against the amino acid position in the three proteins. The probability values were obtained from CodeML analyses of the
seven primate sequences (gray, negative selection; yellow, neutral selection; green, positive selection).
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major clades and several minor ones. These changes were
compared directly with disease-causing mutation data for
three coagulation proteins FVIII, FIX, and FXI. Good-quality
pathogenic mutational data are publicly available for these
three proteins, and the bleeding disorders caused by these
three sets of mutational data correspond to the three most
prevalent bleeding disorders. The outcome of these detailed
analyses confirms that positive selection occurred during dif-
ferent stages in the evolution of several coagulation proteins.
It was also observed, when comparing the protein structure
stabilities, that the pathogenic mutations have a destabilizing
effect on the protein structure as opposed to the stable mu-
tations that are tolerated during evolution (fig. 6). The com-
bination of positive selection analyses with those for
pathogenic mutations provides information about predicting
disease causing mutations and clarifies fresh approaches for
therapeutic interventions in bleeding disorders.
Selective Pressures in Vertebrate Evolution
Evolutionary changes combine random mutational events
with natural selection. The probability of a mutation to be
fixed in a population depends on its consequence on the
fitness of an organism. New adaptive mutations that are ben-
eficial in terms of fitness are more likely to be retained by
positive selection than neutral mutation. Neutral mutations
that are neither beneficial nor detrimental are randomly re-
tained or removed by genetic drift, depending on the popu-
lation size (neutral selection). Detrimental mutations are
more likely to be removed from the population by negative
(or purifying) selection. There are no strict patterns, and a
deleterious mutation can sometimes be beneficial to one
aspect of the organism. The textbook example of this is
sickle-cell anaemia (drepanocytosis) which is a bleeding dis-
order caused by the p.Glu6Val mutation in the hemoglobin 
gene. Mutations responsible for sickle-cell anaemia are gen-
erally removed by natural selection. In malaria-infested pop-
ulations, particularly in tropical or subtropical regions, these
mutations are selected for in one allele because they offer
partial protection against the pathogen (Lopez et al. 2010).
The malaria-infected sickle cells inhibit infection by the ma-
laria plasmodium in heterozygous cases (beneficial), but cause
sickle-cell anaemia in homozygous cases (deleterious).
Genes corresponding to proteins in direct contact with the
environment are more likely to be under adaptive selection.
Thus genes involved in host-pathogen interactions are com-
monly associated with positive selection. Large-scale analyses
revealing positive selection in vertebrates or arthropods have
been reported for genes involved with immunity (Nielsen
et al. 2005; Studer et al. 2008; Montoya-Burgos 2011; Roux
et al. 2014). In the present detailed study, positive selection in
several genes of the coagulation cascade was identified at
FIG. 5. Relationship between disease-causing mutations and evolutionary pressures. The correlation between evolutionary selection and the number of
times a disease-causing mutation occurs at each amino acid position is shown. In the columns, (a) FVIII, (b) FIX, and (c) FXI correspond to the three
coagulation factors for which pathogenic mutational information is available in sufficient quantity from our three mutational databases. The three rows
correspond to the posterior probability (based on the BEB model of CodeML) of positive selection, neutral evolution, and negative selection for
primates.
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different stages in evolution (fig. 3). An earlier study identified
positive selection across six mammalian genomes (human,
chimpanzee, macaque, mouse, rat, and dog) using LRTs
based on codon substitution models and false discovery
rates to evaluate multiple LRT comparisons (Kosiol et al.
2008). Although they found strong positive selection
(P< 0.05 and false discovery rate< 0.05) in nine complement
genes, only nominal positive selection (P< 0.05) was identi-
fied in four coagulation genes (F2, F12, TFPI, PROC), none of
which were identified in figure 3b. A limitation of this earlier
analysis may be the low number of six genomes used. Note
that complement is related to coagulation in that the latter
has the ability to activate complement of innate immunity
that mediates host-pathogen interactions (Amara et al. 2008).
Positive Selection of the Coagulation Proteins through
Host-Pathogen Interactions
As a consequence of the immune response, blood coagula-
tion is often exploited by pathogens for reason of infective
and septic processes. For example, FG and FV are targeted by
bacteria, thus offering a straightforward explanation of posi-
tive selection (fig. 3). We discuss this in terms of FG and FII,
followed by FIII and FVII, and then FV and FX.
By taking advantage of the increased number of available
genome sequences, positive selection has been identified in
several coagulation genes during various stages in evolution.
In particular, all three subunits FGA, FGB, and FGG of FG have
shown positive selection at periods during vertebrate evolu-
tion, according to both the site model and the branch-site
models. Similarly, prothrombin (FII) has shown positive selec-
tion but only across all the vertebrate genomes, and not
across any smaller clades. Although the immune system is
under strong adaptive constraints because it needs to evolve
constantly against pathogens, the coagulation system also
comprises the first line of immune defense against bacteria
to form a clot to block bacterial invasion (Sun 2006). Both FG
and prothrombin (FII) are targeted by certain bacteria. For
example, FG is targeted during the course of infection by
cysteine protease, a virulence factor of Streptococcus pyogenes
(Matsuka et al. 1999) and FG binding protein, Efb, of
Staphylococcus aureus. Similarly, FG-like proteins exist in
Anopheles gambiae and are involved in the function of the
immune system against malaria or bacterial parasites (Dong
and Dimopoulos 2009; Lombardo et al. 2013). Thrombin in-
teracts with staphylocoagulase, a protein secreted by the
human pathogen S. aureus and activates prothrombin with-
out proteolysis to form thrombin. The resulting
FIG. 6. The effect of amino acid replacements on the overall protein stability changeG. Data are shown for (a and b) FVIII A and B chains, (c) FIX (d)
FXI. Three calculations were performed, each being based on the sequences for which crystal structures are known (PDB codes: 2R7E [FVIII], 2WPH [FIX]
and 2F83 [FXI]). The FVIII A and B chains correspond to the N-terminal residues 19–760 and the C-terminal residues 1582–2351 that are observed in its
crystal structure. The calculation represented by the dashed line indicates the distribution calculated for all 19 possible amino acid replacements. That
represented by the dotted line indicates the distribution calculated for all the evolutionary occurring replacements that were observed in our data set of
47 genomes. That represented by the continuous line indicates the distribution calculated for the disease-causing mutations from the FVIII, FIX, and FXI
mutation databases.
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prothrombin—staphylocoagulase complex binds to FG to
cleave this into self-polymerizing fibrin. This process is central
to the molecular pathology of S. aureus endocarditis because
staphylocoagulase bypasses physiological blood coagulation
through the evasion of the recognition of prothrombin by
circulating thrombin inhibitors (Panizzi et al. 2005).
Positive selection for FIII and FVII is attributed to a host-
pathogen interaction with the herpes virus family. These cell
surface molecules do not necessarily participate directly in an
immune response but can still serve as a convenient gateway
for pathogen entry (Vallender and Lahn 2004). Herpes viruses
promote cellular surface infections by coevolving with their
human host, indicating a mode by which pathogens exploit
the coagulation system (Sutherland et al. 2012). A study of the
host-pathogen driven coevolution of herpes virus revealed
that this virus has existed from the time of mammals and
divided into the HSV-1 and HSV-2 types recently during
human evolution (Kolb et al. 2013). These observations sug-
gest that the pressure for FIII to evolve in early mammals,
especially through primates, could be the reason for the pos-
itive selection of FIII across the mammalian clade (fig. 3). We
propose that the FIII–FVII interaction is a significant driving
force for positive selection in FVII.
The FV and FVIII cofactors are homologous to each other
in their sequence and domain organization, hence it is not
surprising to see similar selection pressures acting on them
(fig. 3c). A difference arises in the entire vertebrate genome
(fig. 3a) where FV shows positive selection whereas FVIII does
not. This difference between FV and FVIII across vertebrates
may result from the interaction of FV with Escherichia coli.
The extracellular serine protease EspP from E. coli cleaves FV
to lead to its degradation, and thus reduces the activity of the
coagulation cascade (Brunder et al. 1997). The activated FVa
cofactor forms a FVa/FXa complex with activated FX (fig. 1),
FIG. 7. The effect of amino acid replacements at the sequence level on the protein stability change G. The residue stability changes are depicted on
a seven point scale from highly destabilizing (red) to highly stabilizing (blue) for each of (a) FVIII chain A, (b) FVIII chain B, (c) FIX, and (d) FXI. Their PDB
codes are indicated in figure 6. In each panel, the upper half shows the G values for all the possible 19 amino acid replacements at each residue
position that is part of the crystal structure, and the lower half shows the G values for the disease-causing mutations taken from the mutation
databases.
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which is important for thrombin formation, the most impor-
tant step for fibrin clot formation. Because both FVa and FXa
are central to coagulation, and are associated with bacterial
proteolysis, this offers an explanation for the signatures of
positive selection in both proteins.
FVIII, FIX, and FXIII are also associated with positive selec-
tion; however, it is not clear what selective pressures are in-
volved. Although these proteins may also be targeted by
pathogens, no direct interactions have been reported so far.
Absence of Positive Selection for FXI and FXII
FXII is unique in that it does not show positive selection, even
though it is involved in host-pathogen interactions with long-
chain inorganic phosphatases (polyP) from microorganisms
(Morrissey et al. 2012). Small-chain polyP are produced in the
human brain and by blood platelets. Hence, even during the
absence of pathogen-originated polyP, the human host does
not lack polyP and there is no pressure to evolve for this (Puy
et al. 2013). A F12 deficiency in patients does not cause bleed-
ing disorders. This means that the coagulation cascade can be
initiated even in the absence of F12. For similar reasons, FXI
shows no positive selection. We hypothesize that this is be-
cause, first, no interaction with the environment has been
demonstrated to date, and, second, with respect to the polyP
mechanism, the coagulation cascade is capable of activating
in a FXI-independent manner.
Relationship between Disease-Causing Mutations and
Selection
The mechanisms of genetic drift, mutational change, and
evolutionary change are closely related to each other.
Evolutionary change is not only dependent on the genetic
variability from mutational change, but also on genetic drift,
which describes the random fluctuations in the number of
genetic variants in an organism. Genetic drift and mutations
produce random variations that selection can act upon. The
new changes incurred in one generation may be cancelled in
another generation. It may, therefore, be important to deter-
mine whether a new mutation is lost or becomes common
enough for selection to determine its fate (Masel 2011). In this
study, we have examined the relationship between natural
selection acting on an amino acid and the disease-causing
mutations reported at that amino acid position for the
three prominent coagulation factors FVIII, FIX, and FXI. We
have shown that the disease-causing mutations are more
likely to occur at a higher frequency at sites under negative
selection in all three proteins (fig. 5). As sites under strong
selective pressure are more likely to be critical to protein
function, such a mutation can readily affect protein function
and trigger disease. Lethal (or deleterious) mutations that
cause death are de facto not observed in our data set. By
contrast, disease-causing mutations occur at a reduced fre-
quency in sites under neutral or positive selection, suggesting
that these sites are more tolerant to mutations than sites
under negative selection. Interestingly, we have shown that
FVIII and FIX have undergone much positive selection
whereas FXI has no such signatures (fig. 4). Despite this dif-
ference, our results for three proteins show no change in the
relationship between evolutionary selection and disease-
causing mutations (figs. 5 and 6). In summary, the reported
disease-causing mutations show randomness, and the muta-
bility of a given amino acid position depends on the selection
pressure acting at that position and not on the entire protein.
Effect of Disease-Causing Mutations on the Stability of
Protein Structure
Mutations that change the amino acid sequence can have
striking effects on protein stability. Point mutations are re-
lated to pathological and genetic conditions by reducing or
abolishing coagulation protein function (table 1). Protein
function is related to its stability which is often measured
by the change in folding energyG of the protein structure
(Stefl et al. 2013). We have identified the effect of mutations
on the stability of FVIII, FIX, and FXI in terms of G values.
The stability effects of polymorphic amino acid changes in
human sequences follow a Gaussian distribution (de Beer
et al. 2013). In that study, disease-causing mutations also
showed the same distribution, but slightly skewed toward
destabilization. In this study, the same trend for amino
acids substitutions in vertebrates were observed, but this is
much stronger for disease-causing mutations (fig. 6). The dif-
ference between the two studies may be explained by the
different methods used. de Beer et al. (2013) used the Discrete
Optimized Protein (DOPE) score of Modeller as a monitor of
global stability, whereas we used FoldX (Materials and
Methods) as an empirical method to infer directly the stability
effect G of a point mutation.
Evolutionarily observed mutations are the most stable in
terms of their protein structure, whereas disease-causing mu-
tations destabilized the protein structure (figs. 6 and 7). Each
site may or may not tolerate a particular amino acid change,
depending on the change in stability. When each amino acid
was converted to each of the other 19 possible amino acids
(fig. 7, top panels), the G values showed that most amino
acids destabilize the structure whereas several may stabilize it.
The disease-causing effect of a mutation may be affected, not
only by the selection pressure acting on it, but also by the type
of the amino acid replaced. For the FVIII, FIX, and FXI bleeding
disorders, destabilization was observed for most of the dis-
ease-causing mutations.
Utility of Evolutionary and Disease-Causing
Mutational Analyses for Clinical Diagnosis
Interactive locus-specific databases are useful tools for pre-
senting patient mutational data for patient diagnosis and
care. We plan to incorporate the above data sets on selective
pressures and stability effects into our mutational databases
for FVIII, FIX, and FXI. This information will provide insight for
the prediction of the effect of disease-causing mutations. The
level of selective pressure was estimated under a maximum-
likelihood framework. Such methods are useful for genetic
studies but their results are sometimes difficult to interpret
by a nonspecialist. The presentation of this information needs
to be intuitive to the viewer. As shown in supplementary
figure S3, Supplementary Material online, the use of multiple
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sequence alignments and presentation of stability effects
G, structural locations and selective pressures can help
in interpreting the impacts of the mutations. This type of
information will therefore clarify the interpretation of newly
discovered disease-causing mutations for clinicians, evolu-
tionary biologists, and protein biochemists. This combined
evolutionary-driven study of bleeding disorder-causing muta-
tions is the most detailed of its kind as far as we are aware, and
may be usefully extended to other biological processes and
their proteins.
Materials and Methods
Genomic Sequences
The flowchart of operations is summarized in supplementary
figure S1, Supplementary Material online. First, the complete
multiple sequence alignments were retrieved, together with
their gene trees, for each of the 14 genes corresponding to the
11 coagulation factors (table 1), from the Ensembl Compara
database (Vilella et al. 2009) using their Ensembl IDs (table 1)
and a Perl script. Ensembl release 73 was used, accessed on
September 30, 2013 (Flicek et al. 2013). These amino acid
sequences came from Ensembl, as they are generally of
good quality, and contained 74 vertebrate genomes in a
total of 80 genomes. We then excluded any sequences that
came from genomes of low coverage (2 or less). This re-
sulted in 47 vertebrate genomes with alignment sizes be-
tween 23 and 47 genomes. These 47 sets of vertebrate
sequences provided sufficient genomic coverage to perform
phylogenetic analysis. The 47 vertebrate organisms were clas-
sified into five major clades (fig. 2), namely Primates, Glires
(rodents, rabbits, and pika), Laurasiatheria, Sauropsida (rep-
tiles and birds), and Fishes (ray-finned fishes), together with
minor clades including Atlantogenata and Australian
mammals.
Sequence Retrieval and Multiple Alignments
The multiple sequence alignments and gene trees from
EnsemblCompara included all the coagulation sequences in
different species, irrespective of their genome coverage. The
multiple sequence alignments of the downloaded genes from
the EnsemblCompara database were constructed using a
global alignment algorithm provided within this database
for significant number of sequences of arbitrary lengths.
The data set required for this study comprised 14 genes
from 47 genomes. A thorough quality control procedure of
the multiple sequence alignments was performed in order to
generate minimum false positive results. Thus sequences were
removed if they showed 41% low-complexity regions or
unknown nucleotides (indicated as “N” in a sequence).
From these, the phylogenetic trees were pruned using
Newick Utilities software (Junier and Zdobnov 2010) to iden-
tify the tips corresponding to the retrieved species (fig. 2). The
final alignments of these sequences were made with PRANK,
which is conservative in that it tends to align only amino acids
derived by substitution and introduces insertions and dele-
tions (indels) instead of aligning sequence fragments that
appear too divergent (Loytynoja and Goldman 2008).
PRANK is an advanced probabilistic alignment algorithm
that incorporates phylogenetic information. This has been
shown to reduce the number of false-positives when evalu-
ating positive selection (Fletcher and Yang 2010; Loytynoja
2014). All the PRANK alignments were made using default
parameters for the empirical codon model and the pruned
trees as guides. The resulting alignments are composed of
highly conserved blocks surrounded by noise due to indels.
Finally Gblocks (Castresana 2000) was used to remove the
noise in the unreliable regions of the multiple sequence align-
ments which may cause false positives when testing for pos-
itive selection, to keep only the well-aligned parts. The default
Gblocks parameters for the codontype model (parameter –
t = c) were used, with the exception of tolerating half gaps per
position (parameter -b5=h). This procedure resulted in clean
and accurate multiple sequence alignments for the final com-
putations of the site and branch-site models using CodeML
together with their corresponding gene trees.
Analyses of Evolutionary Pressure
For each of the 14 coagulation genes within each of the five
major clades, the selective pressures were estimated using the
different codon substitution site models implemented in
CodeML of the phylogenetic analysis with maximum-likeli-
hood software (PAML release 4.7) (Yang 2007). By analyzing
the protein-coding genes at the nucleotide level, the synon-
ymous or silent changes (nucleotide substitutions that do not
change the encoded amino acid) are distinguished from the
nonsynonymous or missense changes (substitutions that
change the encoded amino acid). Because natural selection
operates at the protein level, and can take any direction of
positive, neutral or negative selection, the synonymous and
nonsynonymous substitutions are subjected to different se-
lective pressures which occur at the rates dS and dN, respec-
tively. Hence, the ratio of nonsynonymous/synonymous
substitution rates (!= dN/dS) measures the selective pressure
at the protein level. The value of ! reveals the direction and
strength of natural selection acting on the protein. Values of
!< 1, != 1 and !4 1 indicate negative selection, neutral
evolution, and positive selection, respectively. If an existing
function or phenotype is evolutionarily favorable, then nega-
tive selection (or purifying selection) favors the conservation
of that function or phenotype (conservation of amino acids).
The other is positive selection (or Darwinian selection) which
favors the promotion of a new function or phenotype.
Neutral evolution describes the tolerance to amino acid mu-
tations, which are neither deleterious nor beneficial, and are
fixed according to genetic drift.
The following five models were used to account for the
variation of dN/dS among codon sites: M1a (two dN/dS ratios
with negative selection [!0< 1] and neutral evolution
[!1 = 1]); M2a (three dN/dS ratios with negative selection
[!0< 1], neutral evolution [!1 = 1] and positive selection
[!2 1]), M7 (beta); M8 (beta and !24 1); and M8a (beta
and !2 = 1). The alignments contain several positions in
which one of the sequences is missing, and the “cleandata = 0”
option was selected to retain all sites. The inference of positive
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selection was conducted by performing LRTs in which the
following two pairs of models were compared, namely M1a
with M2a, and M8a with M8. The principle is to compare a
null model that does not allow!24 1 (M1a or M8a) with an
alternative model that does (M2a or M8). Because the alter-
nate model has more parameters than the null model, the
LRT follows a 2 distribution. The LRT is a powerful method
for comparing two hypotheses where one is the special case
of the other. The BEB method (Yang et al. 2005) was used to
calculate the posterior probabilities for site classes, and the
BEB value was used to identify sites under positive selection
where the 2 distribution of the LRT was significant with
P< 0.05. As many different LRT comparisons (different
genes different clades) were conducted, a control for the
false-discovery rate (expected proportion of false positives)
was applied using the q value package in R (Storey and
Tibshirani 2003). We adjusted the parameters of the q value
to perform a bootstrap analysis (pi0.meth = “bootstrap”) and
to tolerate 10% of false positives in our significant results
(“fdr.level = 0.1”). A bootstrap analysis is necessary as the P
value distribution is bimodal (Studer et al. 2008).
Two sources for the branch-site model were used. First, the
Selectome database at http://selectome.unil.ch/ (last accessed
January 2014) (Proux et al. 2009; Moretti et al. 2014) provides
the precomputed results of the branch-site model (supple-
mentary table S2b, Supplementary Material online), based on
the multiple sequence alignments from the Ensembl
Compara database (Vilella et al. 2009). The last release of
Selectome (release 6) contains an optimized procedure of
alignment refinement and quality control, similar to the
one used for our site-model analyses, as described above.
The branch-site model allows the dN/dS value to vary, not
only between sites, but also between branches (Zhang et al.
2005). The advantage of this model is its ability to detect
traces of episodic positive selection (Studer and Robinson-
Rechavi 2009a). Second, a branch-site model was determined
based on our data set (see above). We used the vertebrate
trees and their multiple sequence alignments as inputs for
branch-site model calculations. The multiple alignments were
manually rechecked to remove barren sequences, and the
corresponding vertebrate trees were edited accordingly
using Newick Utilities. Each taxonomic unit, also known as
the branch or node of the tree, was tagged using an auto-
mated python script. The CodeML program was run on each
of these tagged trees from all the genes for this branch-site
model (supplementary table S2b, Supplementary Material
online). For some alignments, we found misaligned short in-
sertions up to a maximum of ten amino acids in the con-
served blocks, probably due to gene model prediction errors.
In our whole data set, these errors affect 0–4 sequences per
alignment. As the F2 gene family contained most of these
small errors, albeit at a very low level, this was reanalyzed by
removing four sequences with potential problems from the
alignment. The recalculation of the likelihood ratio deviated
only slightly from the initial results (P value of 3.93e5 for 38
sequences vs. P value of 2.17e4 for 34 sequences). This sug-
gested that these errors would only have a minor impact, if
any, on the detection of positive selection, especially as the
coagulation factor sequences were long, and the model of
codon substitutions was averaged over all columns (many
hundreds) and sequences (between 23 and 47).
Stability Effect of Mutations
When possible for each coagulation factor, the molecular
structures of the domain(s) were retrieved directly from
the CATH database (Sillitoe et al. 2013). Prior to the muta-
tional analyses, each structure was repaired with the FoldX
program (Schymkowitz et al. 2005) to remove potential steric
clashes. FoldX utilizes an empirical force field model to esti-
mate the stability of a protein (Gwildtype in kcal/mol). FoldX
was used to estimate the stability effect on each residue
position when the residue was replaced by any of the 19
other amino acids. The stability effect is determined by
the difference in the wildtype and mutant energies
(G= GmutantGwildtype). This resulted in a stability
landscape of all potential mutations, including the G
values both for the disease mutations and for all the amino
acid substitutions observed across vertebrate evolution.
Statistical Analyses
All statistical analyses were performed with R v3.0.2 (R Core
Team 2013) and SigmaPlot (Systat Software, San Jose, CA).
The pipeline was developed with Biopython scripts (Cock
et al. 2009). The visualization of the multiple sequence align-
ments was performed using Jalview 2.8 (Waterhouse et al.
2009).
Data Availability
The final sequence alignments are provided on a webpage
http://www.biochem.ucl.ac.uk/pavithra/evolution/coagula
tion/index.php (last accessed January 2014). Pathogenic mu-
tation data for three human coagulation factors FVIII, FIX, and
FXI were retrieved from our web databases at http://www.
factorviii-db.org/, http://www.factorix.org/, and http://www.
factorxi.org/ (last accessed January 2014) (Saunders et al.
2009; Rallapalli et al. 2013).
Supplementary Material
Supplementary tables S1–S2 and figures S1–S3 are available at
Molecular Biology and Evolution online (http://www.mbe.
oxfordjournals.org/).
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